Treatment of the lymphomata with ICRF 159 (NSC 129943) adjunctive to combination chemotherapy.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011929:Razoxane / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D010879:Piperazines; D011929:Razoxane